Laura Bohn

Professor and Chair

Scripps Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (10)

Stephen Alexander

Associate Professor

University of Nottingham

UNITED KINGDOM

View details

Christos Iliopoulos_Tsoutsouvas

Research Assistant Professor

Northeastern University

UNITED STATES

View details

Marcel Bermudez

Assistant Professor

University of Münster

GERMANY

View details

Michel Bouvier

Université de Montréal

CANADA

View details

Ioannis P. Papanastasiou

Associate Professor

National and Kapodistrian University of Athens

GREECE

View details

Jeffrey Aubé

Eshelman Distinguished Professor

University of North Carolina

UNITED STATES

View details

Kirill A. Martemyanov

University of Florida

UNITED STATES

View details

Stephen Hill

Professor of Molecular Pharmacology

University of Nottingham

UNITED KINGDOM

View details

Ryan Shenvi

Professor

Scripps Research Institute

UNITED STATES

View details

Fei Tong

Northeastern University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laura Bohn

Research Interests

Explore related searches

Contact this professor

Articles (10)

Comparison of Agonist Activity between CB1 and CB2 Receptors with Orthosteric Site Mutations

Structural and functional insights into the G protein-coupled receptors: CB1 and CB2

A Route to Potent, Selective, and Biased Salvinorin Chemical Space

Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

Community guidelines for GPCR ligand bias: IUPHAR review 32

Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance

Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists

Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism

G protein signaling–biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists

Collaborators (10)

Stephen Alexander

Christos Iliopoulos_Tsoutsouvas

Marcel Bermudez

Michel Bouvier

Ioannis P. Papanastasiou

Jeffrey Aubé

Kirill A. Martemyanov

Stephen Hill

Ryan Shenvi

Fei Tong

Make your next move.